{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:03:52Z","timestamp":1792839832116,"version":"4.5.0"},"reference-count":143,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9,1]]},"abstract":"<jats:p>Autosomal recessive polycystic kidney disease (ARPKD) is an important cause of chronic kidney disease in children. The care of ARPKD patients has traditionally been the realm of pediatric nephrologists; however, the disease has multisystem effects, and a comprehensive care strategy often requires a multidisciplinary team. Most notably, ARPKD patients have congenital hepatic fibrosis, which can lead to portal hypertension, requiring close follow-up by pediatric gastroenterologists. In severely affected infants, the diagnosis is often first suspected by obstetricians detecting enlarged, echogenic kidneys and oligohydramnios on prenatal ultrasounds. Neonatologists are central to the care of these infants, who may have respiratory compromise due to pulmonary hypoplasia and massively enlarged kidneys. Surgical considerations can include the possibility of nephrectomy to relieve mass effect, placement of dialysis access, and kidney and\/or liver transplantation. Families of patients with ARPKD also face decisions regarding genetic testing of affected children, testing of asymptomatic siblings, or consideration of preimplantation genetic diagnosis for future pregnancies. They may therefore interface with genetic counselors, geneticists, and reproductive endocrinologists. Children with ARPKD may also be at risk for neurocognitive dysfunction and may require neuropsychological referral. The care of patients and families affected by ARPKD is therefore a multidisciplinary effort, and the general pediatrician can play a central role in this complex web of care. In this review, we outline the spectrum of clinical manifestations of ARPKD and review genetics of the disease, clinical and genetic diagnosis, perinatal management, management of organ-specific complications, and future directions for disease monitoring and potential therapies.<\/jats:p>","DOI":"10.1542\/peds.2013-3646","type":"journal-article","created":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T00:32:35Z","timestamp":1407803555000},"page":"e833-e845","source":"Crossref","is-referenced-by-count":132,"title":["Autosomal Recessive Polycystic Kidney Disease: A Hepatorenal Fibrocystic Disorder With Pleiotropic Effects"],"prefix":"10.1542","volume":"134","author":[{"given":"Erum A.","family":"Hartung","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Pediatrics, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Guay-Woodford","sequence":"additional","affiliation":[{"name":"Center for Translational Science, Children\u2019s National Health System, Washington, District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2014,9,1]]},"reference":[{"issue":"2","key":"2021120908514656500_B1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1096-8628(19980305)76:2<137::AID-AJMG6>3.0.CO;2-Q","article-title":"Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): molecular genetics, clinical experience, and fetal morphology.","volume":"76","author":"Zerres","year":"1998","journal-title":"Am J Med Genet"},{"issue":"3","key":"2021120908514656500_B2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s004670050281","article-title":"Autosomal recessive polycystic kidney disease: long-term outcome of neonatal survivors.","volume":"11","author":"Roy","year":"1997","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"2021120908514656500_B3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00859625","article-title":"Autosomal recessive polycystic kidney disease.","volume":"3","author":"Kaplan","year":"1989","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"2021120908514656500_B4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF02395759","article-title":"Dominant and recessive polycystic kidney disease in children: classification by intravenous pyelography, ultrasound, and computed tomography.","volume":"18","author":"K\u00e4\u00e4ri\u00e4inen","year":"1988","journal-title":"Pediatr Radiol"},{"issue":"1","key":"2021120908514656500_B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.md.0000200165.90373.9a","article-title":"Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD).","volume":"85","author":"Adeva","year":"2006","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"2021120908514656500_B6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1523-1755.2005.00148.x","article-title":"Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD).","volume":"67","author":"Bergmann","year":"2005","journal-title":"Kidney Int"},{"key":"2021120908514656500_B7"},{"issue":"2","key":"2021120908514656500_B8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00467-002-1021-0","article-title":"Autosomal recessive polycystic kidney disease: outcomes from a single-center experience.","volume":"18","author":"Capisonda","year":"2003","journal-title":"Pediatr Nephrol"},{"issue":"5 pt 1","key":"2021120908514656500_B9","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1542\/peds.111.5.1072","article-title":"Autosomal recessive polycystic kidney disease: the clinical experience in North America.","volume":"111","author":"Guay-Woodford","year":"2003","journal-title":"Pediatrics"},{"issue":"5","key":"2021120908514656500_B10","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1086\/340448","article-title":"PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats.","volume":"70","author":"Onuchic","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"3","key":"2021120908514656500_B11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng833","article-title":"The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein.","volume":"30","author":"Ward","year":"2002","journal-title":"Nat Genet"},{"issue":"9","key":"2021120908514656500_B12","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s10038-006-0022-4","article-title":"Functional analysis of PKHD1 splicing in autosomal recessive polycystic kidney disease.","volume":"51","author":"Bergmann","year":"2006","journal-title":"J Hum Genet"},{"issue":"4","key":"2021120908514656500_B13","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1523-1755.2004.00844.x","article-title":"Polyductin, the PKHD1 gene product, comprises isoforms expressed in plasma membrane, primary cilium, and cytoplasm.","volume":"66","author":"Menezes","year":"2004","journal-title":"Kidney Int"},{"issue":"8","key":"2021120908514656500_B14","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1073\/pnas.0400073101","article-title":"PKHD1 protein encoded by the gene for autosomal recessive polycystic kidney disease associates with basal bodies and primary cilia in renal epithelial cells.","volume":"101","author":"Zhang","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"2021120908514656500_B15","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1097\/01.ASN.0000030392.19694.9D","article-title":"Identification and characterization of Pkhd1, the mouse orthologue of the human ARPKD gene.","volume":"13","author":"Nagasawa","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"20","key":"2021120908514656500_B16","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1093\/hmg\/ddg274","article-title":"Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia.","volume":"12","author":"Ward","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2021120908514656500_B17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/01.ASN.0000113793.12558.1D","article-title":"The autosomal recessive polycystic kidney disease protein is localized to primary cilia, with concentration in the basal body area.","volume":"15","author":"Wang","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"2021120908514656500_B18","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1681\/ASN.2010111173","article-title":"Epitope-tagged Pkhd1 tracks the processing, secretion, and localization of fibrocystin.","volume":"22","author":"Bakeberg","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2021120908514656500_B19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2353\/ajpath.2008.070381","article-title":"Biliary and pancreatic dysgenesis in mice harboring a mutation in Pkhd1.","volume":"172","author":"Gallagher","year":"2008","journal-title":"Am J Pathol"},{"issue":"17","key":"2021120908514656500_B20","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1093\/hmg\/ddq233","article-title":"Polycystic kidney disease protein fibrocystin localizes to the mitotic spindle and regulates spindle bipolarity.","volume":"19","author":"Zhang","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"4","key":"2021120908514656500_B21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/ng0803-355","article-title":"From cilia to cyst.","volume":"34","author":"Watnick","year":"2003","journal-title":"Nat Genet"},{"issue":"08","key":"2021120908514656500_B22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0091-679X(08)94014-0","article-title":"Polycystic kidney disease, cilia, and planar polarity.","volume":"94","author":"Menezes","year":"2009","journal-title":"Methods Cell Biol"},{"issue":"3","key":"2021120908514656500_B23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/ndt\/gfs524","article-title":"The ciliary flow sensor and polycystic kidney disease.","volume":"28","author":"Kotsis","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"2021120908514656500_B24","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1097\/01.ASN.0000141055.57643.E0","article-title":"Intraflagellar transport and cilia-dependent renal disease: the ciliary hypothesis of polycystic kidney disease.","volume":"15","author":"Pazour","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2021120908514656500_B25","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1681\/ASN.2006111215","article-title":"Role of primary cilia in the pathogenesis of polycystic kidney disease.","volume":"18","author":"Yoder","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"16","key":"2021120908514656500_B26","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMra1010172","article-title":"Ciliopathies.","volume":"364","author":"Hildebrandt","year":"2011","journal-title":"N Engl J Med"},{"issue":"46","key":"2021120908514656500_B27","doi-asserted-by":"crossref","first-page":"31559","DOI":"10.1074\/jbc.M805452200","article-title":"Polycystin-2 expression is regulated by a PC2-binding domain in the intracellular portion of fibrocystin.","volume":"283","author":"Kim","year":"2008","journal-title":"J Biol Chem"},{"issue":"3","key":"2021120908514656500_B28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1681\/ASN.2007070770","article-title":"Fibrocystin\/polyductin modulates renal tubular formation by regulating polycystin-2 expression and function.","volume":"19","author":"Kim","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"2021120908514656500_B29","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1128\/MCB.00072-07","article-title":"Fibrocystin\/polyductin, found in the same protein complex with polycystin-2, regulates calcium responses in kidney epithelia.","volume":"27","author":"Wang","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2021120908514656500_B30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ng0697-179","article-title":"PKD1 interacts with PKD2 through a probable coiled-coil domain.","volume":"16","author":"Qian","year":"1997","journal-title":"Nat Genet"},{"issue":"13","key":"2021120908514656500_B31","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.1073\/pnas.94.13.6965","article-title":"Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2.","volume":"94","author":"Tsiokas","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2021120908514656500_B32","first-page":"155","article-title":"Polycystin-1C terminus cleavage and its relation with polycystin-2, two proteins involved in polycystic kidney disease.","volume":"73","author":"Bertuccio","year":"2013","journal-title":"Medicina (B Aires)"},{"key":"2021120908514656500_B33","unstructured":"Autosomal Recessive Polycystic Kidney Disease (ARPKD\/PKHD1) Mutation Database. Available at: http:\/\/www.humgen.rwth-aachen.de. Accessed August 14, 2013"},{"issue":"3","key":"2021120908514656500_B34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/humu.20145","article-title":"Algorithm for efficient PKHD1 mutation screening in autosomal recessive polycystic kidney disease (ARPKD).","volume":"25","author":"Bergmann","year":"2005","journal-title":"Hum Mutat"},{"issue":"5","key":"2021120908514656500_B35","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/humu.20029","article-title":"PKHD1 mutations in autosomal recessive polycystic kidney disease (ARPKD).","volume":"23","author":"Bergmann","year":"2004","journal-title":"Hum Mutat"},{"issue":"5","key":"2021120908514656500_B36","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1681\/ASN.2007010125","article-title":"Genotype-phenotype correlations in autosomal dominant and autosomal recessive polycystic kidney disease.","volume":"18","author":"Rossetti","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2021120908514656500_B37","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/01.ASN.0000039578.55705.6E","article-title":"Spectrum of mutations in the gene for autosomal recessive polycystic kidney disease (ARPKD\/PKHD1).","volume":"14","author":"Bergmann","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"2021120908514656500_B38","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1097\/01.ASN.0000078805.87038.05","article-title":"Milder presentation of recessive polycystic kidney disease requires presence of amino acid substitution mutations.","volume":"14","author":"Furu","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2021120908514656500_B39","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1136\/jmg.2004.024489","article-title":"Comprehensive genomic analysis of PKHD1 mutations in ARPKD cohorts.","volume":"42","author":"Sharp","year":"2005","journal-title":"J Med Genet"},{"issue":"5","key":"2021120908514656500_B40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/humu.20019","article-title":"PKHD1 mutations in families requesting prenatal diagnosis for autosomal recessive polycystic kidney disease (ARPKD).","volume":"23","author":"Bergmann","year":"2004","journal-title":"Hum Mutat"},{"issue":"4","key":"2021120908514656500_B41","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ki.2009.440","article-title":"Genotype-phenotype correlations in fetuses and neonates with autosomal recessive polycystic kidney disease.","volume":"77","author":"Denamur","year":"2010","journal-title":"Kidney Int"},{"issue":"2","key":"2021120908514656500_B42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00439-005-0027-7","article-title":"Analysis of missense variants in the PKHD1-gene in patients with autosomal recessive polycystic kidney disease (ARPKD).","volume":"118","author":"Losekoot","year":"2005","journal-title":"Hum Genet"},{"issue":"2","key":"2021120908514656500_B43","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ymgme.2009.10.010","article-title":"PKHD1 sequence variations in 78 children and adults with autosomal recessive polycystic kidney disease and congenital hepatic fibrosis.","volume":"99","author":"Gunay-Aygun","year":"2010","journal-title":"Mol Genet Metab"},{"issue":"6","key":"2021120908514656500_B44","doi-asserted-by":"crossref","first-page":"972","DOI":"10.2215\/CJN.07141009","article-title":"Correlation of kidney function, volume and imaging findings, and PKHD1 mutations in 73 patients with autosomal recessive polycystic kidney disease.","volume":"5","author":"Gunay-Aygun","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"2021120908514656500_B45","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng0794-429","article-title":"Mapping of the gene for autosomal recessive polycystic kidney disease (ARPKD) to chromosome 6p21-cen.","volume":"7","author":"Zerres","year":"1994","journal-title":"Nat Genet"},{"issue":"6","key":"2021120908514656500_B46","first-page":"1281","article-title":"Refining the map and defining flanking markers of the gene for autosomal recessive polycystic kidney disease on chromosome 6p21.1-p12.","volume":"55","author":"M\u00fccher","year":"1994","journal-title":"Am J Hum Genet"},{"issue":"5","key":"2021120908514656500_B47","first-page":"1101","article-title":"The severe perinatal form of autosomal recessive polycystic kidney disease maps to chromosome 6p21.1-p12: implications for genetic counseling.","volume":"56","author":"Guay-Woodford","year":"1995","journal-title":"Am J Hum Genet"},{"issue":"2","key":"2021120908514656500_B48","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1523-1755.2003.00111.x","article-title":"A complete mutation screen of PKHD1 in autosomal-recessive polycystic kidney disease (ARPKD) pedigrees.","volume":"64","author":"Rossetti","year":"2003","journal-title":"Kidney Int"},{"issue":"4","key":"2021120908514656500_B49","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/gtmb.2009.0188","article-title":"Identification of PKHD1 multiexon deletions using multiplex ligation-dependent probe amplification and quantitative polymerase chain reaction.","volume":"14","author":"Zvereff","year":"2010","journal-title":"Genet Test Mol Biomarkers"},{"issue":"1","key":"2021120908514656500_B50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.ajkd.2004.09.009","article-title":"Haplotype analysis improves molecular diagnostics of autosomal recessive polycystic kidney disease.","volume":"45","author":"Consugar","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2021120908514656500_B51","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMc0801868","article-title":"Perinatal deaths in a family with autosomal dominant polycystic kidney disease and a PKD2 mutation.","volume":"359","author":"Bergmann","year":"2008","journal-title":"N Engl J Med"},{"issue":"7","key":"2021120908514656500_B52","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1681\/ASN.2009101070","article-title":"Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD.","volume":"21","author":"Vujic","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"2021120908514656500_B53","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1681\/ASN.2010101080","article-title":"Mutations in multiple PKD genes may explain early and severe polycystic kidney disease.","volume":"22","author":"Bergmann","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2021120908514656500_B54","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1681\/ASN.2006091057","article-title":"Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys.","volume":"18","author":"Decramer","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2021120908514656500_B55","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1053\/j.gastro.2013.02.046","article-title":"Autosomal-recessive polycystic kidney disease gets more complex.","volume":"144","author":"Bergmann","year":"2013","journal-title":"Gastroenterology"},{"issue":"7","key":"2021120908514656500_B56","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0301-5629(91)90100-B","article-title":"Sonographic, clinical and genetic aspects of prenatal diagnosis of cystic kidney disease.","volume":"17","author":"Reuss","year":"1991","journal-title":"Ultrasound Med Biol"},{"issue":"7","key":"2021120908514656500_B57","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/uog.3856","article-title":"Differential diagnosis of fetal hyperechogenic cystic kidneys unrelated to renal tract anomalies: A multicenter study.","volume":"28","author":"Chaumoitre","year":"2006","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"2021120908514656500_B58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/uog.1098","article-title":"Prenatal sonographic patterns in autosomal dominant polycystic kidney disease: a multicenter study.","volume":"24","author":"Brun","year":"2004","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"2021120908514656500_B59","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ajmg.1320200311","article-title":"Infantile polycystic kidney disease: observations from attempts at prenatal diagnosis.","volume":"20","author":"Luthy","year":"1985","journal-title":"Am J Med Genet"},{"issue":"1","key":"2021120908514656500_B60","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.0009-9163.2004.00259.x","article-title":"New options for prenatal diagnosis in autosomal recessive polycystic kidney disease by mutation analysis of the PKHD1 gene.","volume":"66","author":"Zerres","year":"2004","journal-title":"Clin Genet"},{"issue":"4","key":"2021120908514656500_B61","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/pd.1420","article-title":"Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD) without DNA from an index patient in a current pregnancy.","volume":"26","author":"Gaspar","year":"2006","journal-title":"Prenat Diagn"},{"issue":"1","key":"2021120908514656500_B62","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1472-6483(10)60569-X","article-title":"Preimplantation genetic diagnosis for autosomal recessive polycystic kidney disease.","volume":"16","author":"Gigarel","year":"2008","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"2021120908514656500_B63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/humrep\/deh579","article-title":"ESHRE PGD Consortium \u201cBest practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS).\u201d","volume":"20","author":"Thornhill","year":"2005","journal-title":"Hum Reprod"},{"issue":"7","key":"2021120908514656500_B64","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10815-010-9432-5","article-title":"Birth of a healthy infant following preimplantation PKHD1 haplotyping for autosomal recessive polycystic kidney disease using multiple displacement amplification.","volume":"27","author":"Lau","year":"2010","journal-title":"J Assist Reprod Genet"},{"key":"2021120908514656500_B65"},{"issue":"2","key":"2021120908514656500_B66","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/ndt\/gfl591","article-title":"Antenatal oligohydramnios of renal origin: long-term outcome.","volume":"22","author":"Klaassen","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2021120908514656500_B67","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-3046.2006.00644.x","article-title":"Optimizing outcomes for neonatal ARPKD.","volume":"11","author":"Beaunoyer","year":"2007","journal-title":"Pediatr Transplant"},{"issue":"2","key":"2021120908514656500_B68","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0022-3476(95)70318-7","article-title":"Aggressive respiratory support and unilateral nephrectomy for infants with severe perinatal autosomal recessive polycystic kidney disease.","volume":"127","author":"Bean","year":"1995","journal-title":"J Pediatr"},{"issue":"5 pt 1","key":"2021120908514656500_B69","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1097\/01.ju.0000142025.80132.2f","article-title":"Unilateral nephrectomy as palliative therapy in an infant with autosomal recessive polycystic kidney disease.","volume":"172","author":"Shukla","year":"2004","journal-title":"J Urol"},{"issue":"9","key":"2021120908514656500_B70","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1093\/ndt\/gfn288","article-title":"Nephrectomy in an autosomal recessive polycystic kidney disease (ARPKD) patient with rapid kidney enlargement and increased expression of EGFR.","volume":"23","author":"Arbeiter","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2021120908514656500_B71","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1034\/j.1399-3046.1999.00030.x","article-title":"Bilateral nephrectomy, peritoneal dialysis and subsequent cadaveric renal transplantation for treatment of renal failure due to polycystic kidney disease requiring continuous ventilation.","volume":"3","author":"Spechtenhauser","year":"1999","journal-title":"Pediatr Transplant"},{"issue":"3","key":"2021120908514656500_B72","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0090-4295(93)90621-G","article-title":"Aggressive surgical and medical management of autosomal recessive polycystic kidney disease.","volume":"42","author":"Sumfest","year":"1993","journal-title":"Urology"},{"issue":"5","key":"2021120908514656500_B73","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0022-3476(87)80244-5","article-title":"Polycystic kidney disease in the first year of life.","volume":"111","author":"Cole","year":"1987","journal-title":"J Pediatr"},{"issue":"3","key":"2021120908514656500_B74","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/BF00858681","article-title":"Dominant and recessive polycystic kidney disease in children: evaluation of clinical features and laboratory data.","volume":"2","author":"K\u00e4\u00e4ri\u00e4inen","year":"1988","journal-title":"Pediatr Nephrol"},{"key":"2021120908514656500_B75","first-page":"33","article-title":"Cystic renal diseases in children.","volume":"18","author":"Gagnadoux","year":"1989","journal-title":"Adv Nephrol Necker Hosp"},{"issue":"9","key":"2021120908514656500_B76","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/BF00180750","article-title":"Autosomal recessive polycystic kidney disease.","volume":"70","author":"Zerres","year":"1992","journal-title":"Clin Investig"},{"issue":"12","key":"2021120908514656500_B77","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1007\/s00467-010-1621-z","article-title":"The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease.","volume":"25","author":"Goto","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"2021120908514656500_B78","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000101828","article-title":"Temporal relationship between renal cyst development, hypertension and cardiac hypertrophy in a new rat model of autosomal recessive polycystic kidney disease.","volume":"30","author":"Phillips","year":"2007","journal-title":"Kidney Blood Press Res"},{"issue":"17","key":"2021120908514656500_B79","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","article-title":"Strict blood-pressure control and progression of renal failure in children.","volume":"361","author":"W\u00fchl","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"2021120908514656500_B80","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1590\/S0101-28002010000300007","article-title":"Clinical aspects of autosomal recessive polycystic kidney disease.","volume":"32","author":"Dias","year":"2010","journal-title":"J Bras Neurol"},{"issue":"2","key":"2021120908514656500_B81","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2214\/ajr.160.2.8424350","article-title":"Renal calcifications in patients with autosomal recessive polycystic kidney disease: prevalence and cause.","volume":"160","author":"Lucaya","year":"1993","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"2021120908514656500_B82","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1752-8062.2011.00306.x","article-title":"Congenital hepatic fibrosis in autosomal recessive polycystic kidney disease.","volume":"4","author":"Wen","year":"2011","journal-title":"Clin Transl Sci"},{"issue":"5","key":"2021120908514656500_B83","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/MPG.0b013e31824711b7","article-title":"Congenital hepatic fibrosis and autosomal recessive polycystic kidney disease.","volume":"54","author":"Srinath","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2021120908514656500_B84"},{"issue":"4","key":"2021120908514656500_B85","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/petr.12076","article-title":"New approaches to the autosomal recessive polycystic kidney disease patient with dual kidney-liver complications.","volume":"17","author":"Telega","year":"2013","journal-title":"Pediatr Transplant"},{"key":"2021120908514656500_B86"},{"issue":"20","key":"2021120908514656500_B87","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease.","volume":"354","author":"Grantham","year":"2006","journal-title":"N Engl J Med"},{"issue":"8","key":"2021120908514656500_B88","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1093\/ndt\/16.8.1648","article-title":"Autosomal recessive polycystic kidney disease in adulthood.","volume":"16","author":"Fonck","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"2021120908514656500_B89","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2214\/ajr.164.5.7717240","article-title":"Autosomal recessive polycystic kidney disease: long-term sonographic findings in patients surviving the neonatal period.","volume":"164","author":"Blickman","year":"1995","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"2021120908514656500_B90","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00005792-197107000-00003","article-title":"Infantile polycystic disease of the kidneys and liver: clinical, pathological and radiological correlations and comparison with congenital hepatic fibrosis.","volume":"50","author":"Lieberman","year":"1971","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"2021120908514656500_B91","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00247-001-0624-0","article-title":"Hereditary polycystic kidney diseases in children: changing sonographic patterns through childhood.","volume":"32","author":"Avni","year":"2002","journal-title":"Pediatr Radiol"},{"issue":"3","key":"2021120908514656500_B92","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2214\/ajr.182.3.1820689","article-title":"Complementary role of MRI after sonography in assessing bilateral urinary tract anomalies in the fetus.","volume":"182","author":"Cassart","year":"2004","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"2021120908514656500_B93","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s002470050035","article-title":"Appearance of autosomal recessive polycystic kidney disease in magnetic resonance imaging and RARE-MR-urography.","volume":"30","author":"Kern","year":"2000","journal-title":"Pediatr Radiol"},{"key":"2021120908514656500_B94"},{"issue":"5","key":"2021120908514656500_B95","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00467-011-1771-7","article-title":"Liver fibrosis in recessive multicystic kidney diseases: transient elastography for early detection.","volume":"26","author":"Kummer","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"2021120908514656500_B96","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1111\/j.1399-3046.2009.01167.x","article-title":"End-stage renal disease due to ARPKD in the first months of life: transplantation or dialysis?\u2014two case reports.","volume":"14","author":"Beil","year":"2010","journal-title":"Pediatr Transplant"},{"issue":"8","key":"2021120908514656500_B97","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s004670050680","article-title":"Recurrent bacteremia with enteric pathogens in recessive polycystic kidney disease.","volume":"13","author":"Kashtan","year":"1999","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"2021120908514656500_B98","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1034\/j.1399-3046.2003.00094.x","article-title":"Survival of childhood polycystic kidney disease following renal transplantation: the impact of advanced hepatobiliary disease.","volume":"7","author":"Davis","year":"2003","journal-title":"Pediatr Transplant"},{"key":"2021120908514656500_B99"},{"issue":"4","key":"2021120908514656500_B100","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1034\/j.1600-6143.2002.20412.x","article-title":"Morbidity from congenital hepatic fibrosis after renal transplantation for autosomal recessive polycystic kidney disease.","volume":"2","author":"Khan","year":"2002","journal-title":"Am J Transplant"},{"issue":"11","key":"2021120908514656500_B101","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/lt.21877","article-title":"Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation.","volume":"15","author":"Charlton","year":"2009","journal-title":"Liver Transpl"},{"issue":"11","key":"2021120908514656500_B102","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/j.1600-6143.2008.02416.x","article-title":"Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK).","volume":"8","author":"Eason","year":"2008","journal-title":"Am J Transplant"},{"issue":"6","key":"2021120908514656500_B103","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/tri.12098","article-title":"Combined liver-kidney transplantation for children with autosomal recessive polycystic kidney disease (ARPKD): indication and outcome.","volume":"26","author":"Brinkert","year":"2013","journal-title":"Transpl Int"},{"issue":"1","key":"2021120908514656500_B104","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00467-002-0986-z","article-title":"Recombinant human growth hormone therapy in autosomal recessive polycystic kidney disease.","volume":"18","author":"Lilova","year":"2003","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"2021120908514656500_B105","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1651-2227.1995.tb13538.x","article-title":"Body growth in children with polycystic kidney disease. Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie.","volume":"84","author":"Konrad","year":"1995","journal-title":"Acta Paediatr"},{"issue":"8","key":"2021120908514656500_B106","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.2215\/CJN.09751110","article-title":"Neurocognitive functioning of children and adolescents with mild-to-moderate chronic kidney disease.","volume":"6","author":"Hooper","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"2021120908514656500_B107","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2215\/CJN.00810111","article-title":"Casual blood pressure and neurocognitive function in children with chronic kidney disease: a report of the children with chronic kidney disease cohort study.","volume":"6","author":"Lande","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"2021120908514656500_B108","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00467-012-2215-8","article-title":"Primary hypertension and neurocognitive and executive functioning in school-age children.","volume":"28","author":"Kupferman","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"2021120908514656500_B109","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1751-7176.2012.00661.x","article-title":"Neurocognitive alterations in hypertensive children and adolescents.","volume":"14","author":"Lande","year":"2012","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2021120908514656500_B110"},{"issue":"6","key":"2021120908514656500_B111","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2010-1899","article-title":"Learning and attention problems among children with pediatric primary hypertension.","volume":"126","author":"Adams","year":"2010","journal-title":"Pediatrics"},{"key":"2021120908514656500_B112","article-title":"Neurocognition in children with autosomal recessive polycystic kidney disease in the CKiD Cohort Study [published online ahead of print May 15, 2014].","author":"Hartung","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"2021120908514656500_B113","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2009-0085","article-title":"Health-related quality of life of children with mild to moderate chronic kidney disease.","volume":"125","author":"Gerson","year":"2010","journal-title":"Pediatrics"},{"issue":"2","key":"2021120908514656500_B114","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00467-012-2313-7","article-title":"Health-related quality of life functioning over a 2-year period in children with end-stage renal disease.","volume":"28","author":"Neul","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"2021120908514656500_B115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000314380","article-title":"The mTOR pathway is activated in human autosomal-recessive polycystic kidney disease.","volume":"33","author":"Becker","year":"2010","journal-title":"Kidney Blood Press Res"},{"issue":"6","key":"2021120908514656500_B116","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/ndt\/gfn744","article-title":"Activation of the AKT\/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD).","volume":"24","author":"Fischer","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2021120908514656500_B117","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ndt\/gfq384","article-title":"Inhibition of mTOR with sirolimus does not attenuate progression of liver and kidney disease in PCK rats.","volume":"26","author":"Renken","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"2021120908514656500_B118","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.","volume":"363","author":"Serra","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"2021120908514656500_B119","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease.","volume":"363","author":"Walz","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"2021120908514656500_B120","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ndt\/gfi181","article-title":"Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).","volume":"21","author":"Wahl","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2021120908514656500_B121","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/ndt\/gfm697","article-title":"Sirolimus ameliorates the enhanced expression of metalloproteinases in a rat model of autosomal dominant polycystic kidney disease.","volume":"23","author":"Berthier","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2021120908514656500_B122","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2009040421","article-title":"Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1.","volume":"21","author":"Shillingford","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"14","key":"2021120908514656500_B123","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease.","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2021120908514656500_B124","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2004080660","article-title":"Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease.","volume":"16","author":"Tao","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2021120908514656500_B125","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1523-1755.2000.00991.x","article-title":"cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway.","volume":"57","author":"Yamaguchi","year":"2000","journal-title":"Kidney Int"},{"issue":"7","key":"2021120908514656500_B126","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V1171179","article-title":"cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells.","volume":"11","author":"Hanaoka","year":"2000","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2021120908514656500_B127","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","article-title":"Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys.","volume":"63","author":"Yamaguchi","year":"2003","journal-title":"Kidney Int"},{"issue":"3","key":"2021120908514656500_B128","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1523-1755.2004.00843.x","article-title":"Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.","volume":"66","author":"Belibi","year":"2004","journal-title":"Kidney Int"},{"issue":"39","key":"2021120908514656500_B129","doi-asserted-by":"crossref","first-page":"40419","DOI":"10.1074\/jbc.M405079200","article-title":"Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype.","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"2021120908514656500_B130","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1681\/ASN.2005060645","article-title":"Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells.","volume":"17","author":"Yamaguchi","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2021120908514656500_B131","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1523-1755.1998.00990.x","article-title":"Regulation of cAMP production in initial and terminal inner medullary collecting ducts.","volume":"54","author":"Yasuda","year":"1998","journal-title":"Kidney Int"},{"issue":"10","key":"2021120908514656500_B132","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist.","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat Med"},{"issue":"1","key":"2021120908514656500_B133","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1681\/ASN.2007060688","article-title":"Vasopressin directly regulates cyst growth in polycystic kidney disease.","volume":"19","author":"Wang","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"25","key":"2021120908514656500_B134","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease.","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"2021120908514656500_B135","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/hep.26140","article-title":"Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases.","volume":"58","author":"Masyuk","year":"2013","journal-title":"Hepatology"},{"issue":"9903","key":"2021120908514656500_B136","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0140-6736(13)61407-5","article-title":"Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial.","volume":"382","author":"Caroli","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"2021120908514656500_B137","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00441-006-0226-0","article-title":"Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD).","volume":"326","author":"Sweeney","year":"2006","journal-title":"Cell Tissue Res"},{"issue":"4","key":"2021120908514656500_B138","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1046\/j.1523-1755.2001.00963.x","article-title":"A novel inhibitor of tumor necrosis factor-alpha converting enzyme ameliorates polycystic kidney disease.","volume":"60","author":"Dell","year":"2001","journal-title":"Kidney Int"},{"issue":"4","key":"2021120908514656500_B139","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1046\/j.1523-1755.2003.00232.x","article-title":"Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability.","volume":"64","author":"Sweeney","year":"2003","journal-title":"Kidney Int"},{"issue":"1","key":"2021120908514656500_B140","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0002-9440(10)62231-6","article-title":"Activation of the MEK5\/ERK5 cascade is responsible for biliary dysgenesis in a rat model of Caroli\u2019s disease.","volume":"166","author":"Sato","year":"2005","journal-title":"Am J Pathol"},{"issue":"1","key":"2021120908514656500_B141","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1523-1755.2000.00829.x","article-title":"Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor.","volume":"57","author":"Sweeney","year":"2000","journal-title":"Kidney Int"},{"issue":"7","key":"2021120908514656500_B142","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1681\/ASN.2007060665","article-title":"Src inhibition ameliorates polycystic kidney disease.","volume":"19","author":"Sweeney","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"2021120908514656500_B143"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/134\/3\/e833\/900856\/peds_2013-3646.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/134\/3\/e833\/900856\/peds_2013-3646.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T22:13:27Z","timestamp":1639088007000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/134\/3\/e833\/74150\/Autosomal-Recessive-Polycystic-Kidney-Disease-A"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,1]]},"references-count":143,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,9,1]]},"published-print":{"date-parts":[[2014,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2013-3646","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,1]]}}}